Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials Momentum Sentiment Forecast

Ticker	Company	Market Cap	Price	Price Target	Upside/Downside	Consensus	Analysts	Fore. Revenue Growth	Fore. Earnings Growth	Forecast ROE	Forecast ROA
RIGL	RIGEL PHARMACEUTICALS INC	$777.42M	$42.83	$45.67	6.62%	Buy	3	12.07%	-5.46%	69.74%	33.82%
HCSG	HEALTHCARE SERVICES GROUP INC	$1.35B	$19.12	$19.40	1.46%	Buy	5	9.11%	80.25%	16.73%	10.32%
ATRC	ATRICURE INC	$1.97B	$39.56	$52.33	32.29%	Strong Buy	3	14.64%	N/A	5.96%	4.47%
CRL	CHARLES RIVER LABORATORIES INTERNATIONAL INC	$9.82B	$199.48	$197.89	-0.80%	Buy	9	3.58%	N/A	20.76%	9.41%
SNWV	SANUWAVE HEALTH INC	$255.91M	$29.84	N/A	N/A	N/A	N/A	43.80%	N/A	-568.85%	46.84%
FBIO	FORTRESS BIOTECH INC	$113.60M	$3.66	$17.00	364.48%	Buy	1	79.32%	N/A	-111.65%	-34.38%
BLCO	BAUSCH & LOMB CORP	$6.05B	$17.08	$17.50	2.46%	Buy	10	6.55%	N/A	9.24%	4.30%
NVST	ENVISTA HOLDINGS CORP	$3.57B	$21.71	$21.00	-3.27%	Buy	9	5.13%	299.52%	8.39%	4.59%
DHR	DANAHER CORP	$161.70B	$228.92	$245.75	7.35%	Strong Buy	12	6.31%	28.61%	15.74%	10.06%
MNKD	MANNKIND CORP	$1.74B	$5.67	$10.08	77.83%	Strong Buy	6	21.75%	60.18%	-453.45%	40.84%
TMO	THERMO FISHER SCIENTIFIC INC	$217.70B	$579.45	$631.31	8.95%	Strong Buy	16	6.06%	20.81%	25.53%	12.64%
OGN	ORGANON & CO	$1.86B	$7.17	$9.50	32.50%	Strong Sell	3	1.20%	30.40%	120.28%	8.04%
IDYA	IDEAYA BIOSCIENCES INC	$3.03B	$34.57	$49.70	43.77%	Strong Buy	10	0.44%	N/A	-12.11%	-11.16%
HBIO	HARVARD BIOSCIENCE INC	$29.82M	$0.67	$2.00	198.95%	Buy	1	N/A	N/A	30.71%	5.54%
PODD	INSULET CORP	$20.00B	$284.24	$380.67	33.92%	Strong Buy	12	22.32%	40.92%	58.45%	26.70%
ZVRA	ZEVRA THERAPEUTICS INC	$504.43M	$8.96	$23.00	156.70%	Strong Buy	4	53.54%	77.67%	139.83%	68.93%
SLNO	SOLENO THERAPEUTICS INC	$2.49B	$46.30	$104.67	126.06%	Strong Buy	6	377.21%	N/A	75.04%	61.89%
IMCR	IMMUNOCORE HOLDINGS PLC	$1.75B	$34.71	$65.33	88.23%	Buy	3	20.22%	N/A	34.98%	12.58%
ATEC	ALPHATEC HOLDINGS INC	$3.13B	$21.04	$22.40	6.46%	Strong Buy	10	18.49%	N/A	N/A	N/A
ANIK	ANIKA THERAPEUTICS INC	$138.59M	$9.61	$16.00	66.49%	Buy	1	46.67%	N/A	-3.41%	-2.64%
SEM	SELECT MEDICAL HOLDINGS CORP	$1.84B	$14.85	$16.33	9.99%	Buy	3	45.18%	52.95%	11.20%	3.33%
EW	EDWARDS LIFESCIENCES CORP	$49.45B	$85.25	$95.83	12.41%	Strong Buy	18	11.72%	16.04%	23.45%	18.03%
SYK	STRYKER CORP	$134.41B	$351.47	$427.11	21.52%	Strong Buy	9	9.62%	34.07%	34.27%	15.87%
CI	CIGNA GROUP	$73.52B	$275.23	$335.67	21.96%	Strong Buy	9	6.85%	19.07%	27.78%	7.35%
LGND	LIGAND PHARMACEUTICALS INC	$3.72B	$189.07	$243.50	28.79%	Strong Buy	6	14.25%	69.75%	25.11%	16.16%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$2.16B	$37.42	$45.00	20.26%	Strong Buy	6	16.87%	36.05%	77.91%	53.85%
NEOG	NEOGEN CORP	$1.52B	$6.99	$8.25	18.03%	Buy	2	-0.32%	N/A	4.60%	2.89%
ALHC	ALIGNMENT HEALTHCARE INC	$3.95B	$19.75	$20.17	2.11%	Strong Buy	6	29.38%	N/A	N/A	N/A
DXCM	DEXCOM INC	$25.89B	$66.37	$85.45	28.75%	Strong Buy	20	14.60%	26.22%	64.31%	23.37%
HCM	HUTCHMED (CHINA) LTD	$2.32B	$13.33	$20.88	56.60%	Hold	2	17.82%	-1.59%	N/A	N/A
FHTX	FOGHORN THERAPEUTICS INC	$305.38M	$5.40	$11.67	116.06%	Strong Buy	3	31.44%	N/A	N/A	-11.88%
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.30B	$7.85	$10.83	38.00%	Buy	6	24.03%	N/A	N/A	N/A
TGTX	TG THERAPEUTICS INC	$4.73B	$29.81	$54.67	83.38%	Strong Buy	3	40.81%	-1.61%	98.01%	58.06%
IQV	IQVIA HOLDINGS INC	$38.32B	$225.41	$241.21	7.01%	Strong Buy	14	6.62%	29.65%	50.40%	10.81%
PBYI	PUMA BIOTECHNOLOGY INC	$299.83M	$5.95	N/A	N/A	N/A	N/A	1.75%	-7.79%	20.51%	11.65%
GYRE	GYRE THERAPEUTICS INC	$680.11M	$7.06	$17.00	140.79%	Strong Buy	2	53.30%	N/A	64.59%	41.31%
APLS	APELLIS PHARMACEUTICALS INC	$3.18B	$25.12	$36.00	43.31%	Buy	14	7.81%	36.38%	59.45%	22.52%
BWAY	BRAINSWAY LTD	$359.38M	$19.02	$23.50	23.55%	Buy	2	339.91%	109.29%	58.44%	36.21%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$2.48B	$16.24	$18.43	13.48%	Strong Buy	7	16.17%	N/A	-14.47%	-6.03%
TNGX	TANGO THERAPEUTICS INC	$1.19B	$8.86	$12.40	39.95%	Strong Buy	5	9.04%	N/A	-39.18%	-29.83%
PTCT	PTC THERAPEUTICS INC	$6.10B	$75.96	$78.54	3.39%	Buy	13	-5.29%	-26.33%	-344.38%	20.29%
GMAB	GENMAB A	$19.78B	$30.80	$43.75	42.05%	Strong Buy	4	16.73%	133.44%	31.20%	25.56%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$3.13B	$41.25	$51.33	24.44%	Strong Buy	6	25.55%	80.85%	41.88%	31.47%
ITGR	INTEGER HOLDINGS CORP	$2.75B	$78.43	$86.67	10.50%	Buy	6	5.77%	46.32%	16.99%	8.73%
JNJ	JOHNSON & JOHNSON	$498.60B	$206.95	$212.21	2.54%	Buy	14	6.03%	8.60%	43.95%	18.07%
PNTG	PENNANT GROUP INC	$973.81M	$28.15	$34.80	23.62%	Strong Buy	5	38.80%	71.50%	17.13%	7.32%
HALO	HALOZYME THERAPEUTICS INC	$7.91B	$67.30	$77.13	14.60%	Buy	8	18.07%	29.40%	218.75%	49.63%
PEN	PENUMBRA INC	$12.18B	$310.91	$330.67	6.35%	Strong Buy	12	15.10%	22.71%	24.67%	19.21%
CDNA	CAREDX INC	$968.99M	$18.84	$23.00	22.08%	Buy	3	15.74%	6.80%	32.54%	23.42%
CERT	CERTARA INC	$1.40B	$8.81	$13.29	50.81%	Strong Buy	7	8.60%	119.69%	16.17%	11.21%
OWLT	OWLET INC	$446.53M	$16.19	$20.00	23.53%	Buy	1	28.17%	N/A	-56.64%	40.96%
CPRX	CATALYST PHARMACEUTICALS INC	$2.87B	$23.34	$33.00	41.39%	Strong Buy	1	9.04%	18.84%	57.36%	50.19%
WST	WEST PHARMACEUTICAL SERVICES INC	$19.79B	$275.14	$338.00	22.85%	Strong Buy	7	7.36%	13.41%	25.76%	19.15%
ARGX	ARGENX SE	$51.33B	$840.95	$1.03k	22.12%	Strong Buy	15	1,549.26%	23.80%	56.41%	47.92%
ASRT	ASSERTIO HOLDINGS INC	$58.20M	$9.07	$45.00	396.14%	Buy	1	0.13%	N/A	3.03%	1.00%
SOLV	SOLVENTUM CORP	$13.74B	$79.24	$90.33	14.00%	Buy	6	0.21%	-9.69%	27.64%	9.86%
PRE	PRENETICS GLOBAL LTD	$218.85M	$15.75	$32.00	103.17%	Strong Buy	1	230.78%	N/A	47.25%	38.78%
CERS	CERUS CORP	$395.70M	$2.06	N/A	N/A	N/A	N/A	9.46%	N/A	3.19%	0.91%
TMDX	TRANSMEDICS GROUP INC	$4.16B	$121.65	$143.43	17.90%	Buy	7	20.37%	17.26%	N/A	N/A
HQY	HEALTHEQUITY INC	$7.83B	$91.61	$120.00	30.99%	Strong Buy	10	5.48%	44.82%	21.31%	13.38%
PGNY	PROGYNY INC	$2.21B	$25.68	$27.38	6.60%	Buy	8	10.77%	47.98%	36.43%	25.65%
EHC	ENCOMPASS HEALTH CORP	$10.68B	$106.14	$148.00	39.44%	Strong Buy	5	10.06%	9.20%	29.80%	10.30%
DOCS	DOXIMITY INC	$8.34B	$44.28	$67.80	53.12%	Buy	15	9.23%	13.38%	37.69%	32.84%
CON	CONCENTRA GROUP HOLDINGS PARENT INC	$2.52B	$19.68	$31.00	57.52%	Strong Buy	1	9.26%	20.95%	63.92%	8.66%
QGEN	QIAGEN NV	$9.79B	$44.97	$51.67	14.89%	Buy	3	7.96%	19.18%	20.90%	11.64%
BNR	BURNING ROCK BIOTECH LTD	$217.10M	$20.15	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LMAT	LEMAITRE VASCULAR INC	$1.84B	$81.10	$97.75	20.53%	Buy	4	10.77%	9.25%	19.66%	12.46%
ZYME	ZYMEWORKS INC	$1.97B	$26.33	$32.75	24.38%	Strong Buy	8	20.08%	N/A	7.87%	6.34%
GDRX	GOODRX HOLDINGS INC	$919.86M	$2.71	$4.33	59.89%	Hold	6	6.72%	101.43%	57.64%	26.12%
ILMN	ILLUMINA INC	$20.04B	$131.16	$116.00	-11.56%	Hold	12	5.40%	13.15%	47.02%	18.12%
NVS	NOVARTIS AG	$265.54B	$137.87	$118.00	-14.41%	Strong Sell	1	3.99%	14.22%	53.06%	21.92%
LFST	LIFESTANCE HEALTH GROUP INC	$2.74B	$7.04	$9.00	27.84%	Strong Buy	4	17.78%	N/A	N/A	N/A
ICUI	ICU MEDICAL INC	$3.52B	$142.67	$175.67	23.13%	Strong Buy	3	3.33%	N/A	14.24%	7.38%
LH	LABCORP HOLDINGS INC	$20.80B	$250.88	$308.75	23.07%	Strong Buy	8	6.25%	27.95%	20.39%	9.71%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.23B	$26.78	$30.25	12.96%	Hold	4	4.53%	19.80%	22.99%	10.72%
REGN	REGENERON PHARMACEUTICALS INC	$81.12B	$771.87	$787.63	2.04%	Buy	16	8.17%	10.23%	21.11%	16.27%
XOMA	XOMA ROYALTY CORP	$329.27M	$26.59	$72.67	173.29%	Strong Buy	3	44.65%	-61.19%	17.10%	5.71%
OPCH	OPTION CARE HEALTH INC	$5.06B	$31.86	$35.29	10.75%	Strong Buy	7	9.94%	25.15%	33.72%	13.17%
ACAD	ACADIA PHARMACEUTICALS INC	$4.52B	$26.71	$31.08	16.37%	Buy	12	12.14%	5.80%	45.58%	31.42%
BAX	BAXTER INTERNATIONAL INC	$9.82B	$19.11	$24.38	27.55%	Hold	8	2.69%	N/A	21.08%	7.25%
DCTH	DELCATH SYSTEMS INC	$356.67M	$10.10	$23.00	127.72%	Strong Buy	4	33.77%	222.26%	53.40%	49.34%
KRYS	KRYSTAL BIOTECH INC	$7.15B	$246.54	$217.80	-11.66%	Buy	5	36.80%	30.09%	75.26%	69.06%
BTMD	BIOTE CORP	$118.72M	$2.60	$4.00	53.85%	Hold	1	9.44%	2.26%	-78.11%	51.04%
SIBN	SI-BONE INC	$855.68M	$19.72	$25.00	26.77%	Strong Buy	5	18.26%	N/A	N/A	N/A
EVAX	EVAXION A	$30.13M	$4.77	$12.33	158.55%	Strong Buy	3	84.88%	N/A	517.42%	143.50%
SPRO	SPERO THERAPEUTICS INC	$131.27M	$2.33	N/A	N/A	N/A	N/A	-10.48%	N/A	N/A	N/A
AZTA	AZENTA INC	$1.52B	$33.26	$40.00	20.26%	Buy	4	5.84%	N/A	3.39%	2.84%
HAE	HAEMONETICS CORP	$3.75B	$80.15	$85.63	6.83%	Buy	8	3.35%	27.06%	34.05%	11.84%
HNGE	HINGE HEALTH INC	$3.66B	$46.45	$63.91	37.59%	Strong Buy	11	N/A	N/A	112.34%	30.35%
CVS	CVS HEALTH CORP	$100.74B	$79.36	$95.53	20.38%	Strong Buy	15	5.79%	185.75%	16.88%	4.82%
TFX	TELEFLEX INC	$5.39B	$122.04	$132.25	8.37%	Hold	4	8.53%	N/A	22.04%	10.70%
FLGT	FULGENT GENETICS INC	$812.07M	$26.27	$30.00	14.20%	Buy	2	12.64%	N/A	-0.59%	-0.55%
WRBY	WARBY PARKER INC	$2.66B	$21.79	$27.71	27.19%	Buy	7	18.39%	4,822.00%	24.19%	12.65%
VRCA	VERRICA PHARMACEUTICALS INC	$78.86M	$8.31	$17.00	104.57%	Strong Buy	1	62.26%	N/A	-409.01%	170.42%
MEDP	MEDPACE HOLDINGS INC	$15.82B	$561.65	$494.60	-11.94%	Sell	10	13.79%	11.84%	216.48%	36.26%
CRMD	CORMEDIX INC	$916.32M	$11.63	$18.40	58.21%	Buy	5	29.70%	5.75%	70.46%	35.11%
ESPR	ESPERION THERAPEUTICS INC	$884.53M	$3.70	$12.50	237.84%	Strong Buy	2	22.44%	N/A	-137.76%	170.82%
ENSG	ENSIGN GROUP INC	$10.09B	$174.20	$206.50	18.54%	Strong Buy	4	20.39%	28.50%	22.20%	9.00%
WAT	WATERS CORP	$22.61B	$379.83	$386.11	1.65%	Buy	9	7.17%	17.04%	49.64%	23.79%
PACS	PACS GROUP INC	$6.01B	$38.39	$39.67	3.33%	Strong Buy	3	13.61%	89.96%	41.94%	6.49%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	615	+0.27%	-2.56%	+0.97%	-41.73%	146.65x	5.25x	-24.86%	-9.63%	-5.94%	+53.28%	Strong Buy
Diagnostics & Research	57	-0.98%	-1.53%	-3.92%	+15.95%	22.62x	4.43x	-1.14%	+6.19%	+13.13%	+8.73%	Buy
Drug Manufacturers - General	20	-0.36%	-0.64%	+0.75%	+29.59%	46.13x	6.93x	+106.72%	+12.28%	+20.38%	+4.48%	Buy
Drug Manufacturers - Specialty & Generic	77	-0.56%	-2.69%	+2.08%	-2.13%	-31.58x	2.36x	+9.51%	+2.96%	+5.96%	+55.56%	Strong Buy
Healthcare Plans	10	-0.12%	+1.21%	+5.01%	-15.66%	43.65x	2.07x	+12.19%	+3.78%	+9.23%	+14.08%	Buy
Health Information Services	54	-1.69%	-1.94%	-3.58%	-49.84%	42.11x	3.83x	+8.87%	+4.67%	+6.54%	+39.06%	Strong Buy
Medical Care Facilities	50	-1.25%	-1.53%	-4.54%	-42.75%	15.02x	5.23x	-80.60%	+7.33%	+16.04%	+20.06%	Buy
Medical Devices	139	+0.40%	-1.57%	-14.79%	-92.02%	23.79x	3.87x	+11.80%	+7.14%	+8.17%	+38.40%	Strong Buy
Medical Distribution	10	-0.79%	-0.70%	-3.80%	+44.38%	31.24x	3,562.64x	-56.46%	+3.41%	+21.83%	+9.05%	Buy
Medical Instruments & Supplies	57	-0.94%	-1.78%	+0.33%	-31.91%	222.67x	3.29x	+10.08%	+8.62%	+11.38%	+15.84%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jan 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #1 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 38, which is 12 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock lose -23.93% over the past year, overperforming other healthcare stocks by 39 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $3.00, a downside of -10.98% from Ironwood Pharmaceuticals's current stock price of $3.37.

Ironwood Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #2 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 63.03% over the past year, overperforming other healthcare stocks by 126 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -0.27% from Pediatrix Medical Group's current stock price of $21.39.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #3 top healthcare stock out of 1089 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: A.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 29, which is 3 points higher than the healthcare sector average of 26. It passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 75.56% over the past year, overperforming other healthcare stocks by 138 percentage points.

What are the healthcare stocks with highest dividends?

Out of 69 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.91%, which is 9 percentage points higher than the healthcare sector average of 1.92%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.48%, which is 8 percentage points higher than the healthcare sector average of 1.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 5.6%, which is 4 percentage points higher than the healthcare sector average of 1.92%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.6% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and down -1.76% over the last week. Corcept Therapeutics was the among the top losers in the healthcare sector, dropping -50.42% yesterday.

Corcept Therapeutics shares are trading lower after the company announced it received a Complete Response Letter for Relacorilant from the FDA.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -51.94% in the past year. It has overperformed other stocks in the healthcare sector by 11 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 8.75% in the past year. It has overperformed other stocks in the healthcare sector by 71 percentage points.

3. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -13.77% in the past year. It has overperformed other stocks in the healthcare sector by 49 percentage points.

Are healthcare stocks a good buy now?

57.52% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 31.56% over the next year.

7.72% of healthcare stocks have a Zen Rating of A (Strong Buy), 11.81% of healthcare stocks are rated B (Buy), 47.84% are rated C (Hold), 24.68% are rated D (Sell), and 7.95% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 62.53x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Pediatrix Medical Group (NYSE:MD)

3. Pharming Group Nv (NASDAQ:PHAR)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Dentsply Sirona (NASDAQ:XRAY)

1. Organon & Co (NYSE:OGN)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Bausch Health Companies (NYSE:BHC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.